Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
Claudia Abbruzzese et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
Hua-Hao Fan et al.
CHINESE MEDICAL JOURNAL (2020)
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
Zheng Ye et al.
EUROPEAN RADIOLOGY (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
Zahra Sahraei et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
Caring for patients with cancer in the COVID-19 era
Joris van de Haar et al.
NATURE MEDICINE (2020)
Audio Interview: New Research on Possible Treatments for Covid-19
Eric J. Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
Bronwyn M. Gunn et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress
Naomi X. Y. Ling et al.
NATURE METABOLISM (2020)
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
Silvia Matteoni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221
Anna V. Tinker et al.
CLINICAL CANCER RESEARCH (2019)
Cellular therapy: Immune-related complications
Joseph H. Oved et al.
IMMUNOLOGICAL REVIEWS (2019)
The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
Joshua Casaos et al.
MOLECULAR CANCER THERAPEUTICS (2019)
The 1918 influenza pandemic: 100 years of questions answered and unanswered
Jeffery K. Taubenberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer
Gregory A. Joice et al.
NATURE REVIEWS UROLOGY (2019)
Lopinavir-Ritonavir Combination Induces Endoplasmic Reticulum Stress and Kills Urological Cancer Cells
Kazuki Okubo et al.
ANTICANCER RESEARCH (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Cedric Magaway et al.
CELLS (2019)
Molecular logic of mTORC1 signalling as a metabolic rheostat
Alexander J. Valvezan et al.
NATURE METABOLISM (2019)
Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections
Dana T. Lounder et al.
BLOOD ADVANCES (2019)
Association of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses A 60-Year Follow-up of a Clinical Trial
Nicholas T. Usher et al.
JAMA NETWORK OPEN (2019)
AMPK: guardian of metabolism and mitochondrial homeostasis
Sebastien Herzig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Waleed H. Mahallawi et al.
CYTOKINE (2018)
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells
Rocco Spagnuolo et al.
INFLAMMATORY BOWEL DISEASES (2018)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Comprehending a Killer: The Akt/mTOR Signaling Pathways Are Temporally High-Jacked by the Highly Pathogenic 1918 Influenza Virus
Charlene Ranadheera et al.
EBIOMEDICINE (2018)
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Fabiana Conciatori et al.
CANCERS (2018)
Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review
Lingdi Zhao et al.
IMMUNOTHERAPY (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
NKG2A, a New Kid on the Immune Checkpoint Block
John B. Haanen et al.
CELL (2018)
Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
Nirmala Chandralega Kampan et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Interleukin-6 induces drug resistance in renal cell carcinoma
Kei Ishibashi et al.
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (2018)
Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic
F. Volpin et al.
ONCOGENE (2017)
Drug repurposing for the treatment of glioblastoma multiforme
Claudia Abbruzzese et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
Claudia Abbruzzese et al.
ONCOTARGET (2017)
Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-1 induced epithelial-mesenchymal transition
Xinrui Tian et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand
Tamir Epstein et al.
PLOS ONE (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
Karen L. Bride et al.
BLOOD (2016)
Host cell mTORC1 is required for HCV RNA replication
Stefanie Stoehr et al.
GUT (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Zhiyu Wang et al.
CURRENT DRUG TARGETS (2016)
Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies
Steve Pascolo
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Lynne Hampson et al.
PLOS ONE (2016)
Metabolic regulation of natural killer cells
David K. Finlay
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation
Lucia D'Antona et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Role of autophagy in the maintenance and function of cancer stem cells
Ilio Vitale et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2015)
Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms
Bridget Freyne et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2015)
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy
Cristina Talarico et al.
Oncotarget (2015)
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
Jason Kindrachuk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
Tom W. J. Huizinga et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure
Chun-Hua Wang et al.
CRITICAL CARE MEDICINE (2014)
Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
Tomonori Kimura et al.
CANCER RESEARCH (2013)
Cidofovir: A Novel Antitumor Agent for Glioblastoma
Piotr Hadaczek et al.
CLINICAL CANCER RESEARCH (2013)
Host mTORC1 Signaling Regulates Andes Virus Replication
Shannon McNulty et al.
JOURNAL OF VIROLOGY (2013)
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
Chuan Wu et al.
NATURE (2013)
Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells
R. Amato et al.
ONCOGENE (2013)
Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo
Bruno Garulli et al.
VACCINE (2013)
Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
Belinda Seto
CLINICAL AND TRANSLATIONAL MEDICINE (2012)
Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion
Graham Simmons et al.
VIROLOGY (2011)
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action
Jan Paeshuyse et al.
CURRENT OPINION IN VIROLOGY (2011)
BCG vaccination and reduced risk of asthma
Adelmir Souza-Machado et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2010)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
Jeremy Copp et al.
CANCER RESEARCH (2009)
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation
Rosario Amato et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Anakinra for rheumatoid arthritis
Marty Mertens et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Tocilizumab: The first interleukin-6-receptor inhibitor
Anthony Sebba
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
Masakazu Kono et al.
ANTIVIRAL RESEARCH (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme
Eduardo Briceno et al.
SURGICAL NEUROLOGY (2007)
Adding chloroquine to conventional treatment for glioblastoma multiforme -: A randomized, double-blind, placebo-controlled trial
J Sotelo et al.
ANNALS OF INTERNAL MEDICINE (2006)
Non-small-cell lung cancer vaccine therapy: A concise review
D O'Mahony et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Glycoconjugate glycans as viral receptors
S Olofsson et al.
ANNALS OF MEDICINE (2005)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion
ED Schwoebel et al.
JOURNAL OF CELL BIOLOGY (2002)
Share Paper
